STOCK TITAN

Esperion to Report Third Quarter 2022 Financial Results November 1, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
conferences earnings
Rhea-AI Summary

Esperion (NASDAQ: ESPR) is set to announce its third quarter 2022 financial results on November 1, 2022, before U.S. markets open. Following the release, company management will host a webcast at 8:00 a.m. ET to discuss the results and business progress. Interested parties can pre-register for the webcast through their official website, where a replay will also be available approximately two hours after the call, archived for 90 days.

Esperion is focused on developing innovative cholesterol-lowering medications for patients with unmet needs.

Positive
  • None.
Negative
  • None.

ANN ARBOR, Mich., Oct. 17, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report third quarter 2022 financial results before the open of the U.S. financial markets on Tuesday, November 1st, 2022.

Following the release, company management will host a webcast at 8:00 a.m. ET to discuss the Company’s financial results and business progress. Please click here to pre-register to participate in the conference call and obtain your dial in number and PIN.

Already registered? Access with your PIN here

A live audio webcast can be accessed on the investors and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after completion of the call and will be archived on the Company's website for approximately 90 days.

Esperion Therapeutics
Esperion works hard to make our medicines easy to get, easy to take and easy to have. We discover, develop, and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate, and resourceful. We are singularly focused on managing cholesterol so you can improve your health easily. For more information, please visit www.esperion.com and follow us on Twitter at www.twitter.com/EsperionInc.

Contact:
Corporate Communications
corporateteam@esperion.com


FAQ

When will Esperion report its third quarter 2022 financial results?

Esperion will report its third quarter 2022 financial results on November 1, 2022.

What time is Esperion's Q3 2022 earnings webcast?

The Q3 2022 earnings webcast will be held at 8:00 a.m. ET on November 1, 2022.

How can I access the Esperion Q3 2022 earnings call?

You can access the earnings call by pre-registering on Esperion's official website.

Will there be a replay of the Esperion earnings call?

Yes, a replay of the earnings call will be available approximately two hours after the event and archived for 90 days.

What does Esperion specialize in?

Esperion specializes in discovering, developing, and commercializing innovative cholesterol-lowering medications.

Esperion Therapeutics, Inc.

NASDAQ:ESPR

ESPR Rankings

ESPR Latest News

ESPR Stock Data

409.23M
196.09M
0.48%
65.97%
12.93%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
ANN ARBOR